Kovack Advisors, Inc. Enzon Pharmaceuticals, Inc. Call Options Transaction History
Kovack Advisors, Inc.
- $919 Million
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
About ENZON PHARMACEUTICALS, INC.
- Ticker ENZN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 74,214,600
- Market Cap $6.68M
- Description
- Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.